Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

A(1-7) treatment reduces symptoms of lupus in mice.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

p2y5, now called LPA6, is a receptor important for human hair growth.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Peps help Arabidopsis plants grow more root hairs by affecting specific genes and calcium signaling.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Allopregnanolone, a progesterone metabolite, helps reduce restraint effects on behavior.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Two new compounds were found to effectively reduce hair growth in mice.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

PDRN from trout sperm helps skin and hair regeneration but is costly and complex to produce.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

New progesterone-based compounds can block male hormones.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Platelet-rich plasma (PRP) is an effective treatment for lichen planopilaris.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

ALRN-6924 may prevent hair loss caused by chemotherapy.